Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Derivatives -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (208)	5/14/1999 3:05:00 PM
From: LLCF	Respond to of 555

Just think if it was Descarboethoxyloratadine! DAK

To: scaram(o)uche who wrote (208)	5/14/1999 3:11:00 PM
From: LLCF	Read Replies (2) \| Respond to of 555

I bet that the buyers and sellers in the stock right now don't have any more visability (probably less) than one gets by reading the SEPR threads last 10 posts....... "don't just stand there DO SOMETHING!" -trading desks all over the country. DAK

To: scaram(o)uche who wrote (208)	7/13/1999 1:14:00 PM
From: LLCF	Read Replies (1) \| Respond to of 555

Maybe we can use this thread for market commentary [chatting]???? Wonder where we should do that. Anyway, from the BTRN thread, 507 data: <Very good results, no matter how you cut the data.> It looks like some analyst somewhere has figured it out. It is very interesting that the Genome group news [HGSI hype] 1.) got noticed 2.) only a couple days later and 3.) with dramatic revaluation.... now BTRN previously known as "Motel Roche" actually gets noticed on trial data. There are certainly new players in the sector and I believe it behoove trader types [myself?] to change their returns expectations paradigm or get lost in the dust. Wonder what could happen if the big institutions get back in the game. DAK